Use of derivatives of 2, 4-dihydro-(1,2,4)triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (MPO)

Details for Australian Patent Application No. 2004234320 (hide)

Owner AstraZeneca AB

Inventors Tiden, Anna-Karin; Turek, Dominika; Svensson, Mats

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004234320

PCT Pub. Number WO2004/096781

Priority 0301232-5 25.04.03 SE

Filing date 22 April 2004

Wipo publication date 11 November 2004

International Classifications

C07D 249/12 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61P 025/28 Drugs for disorders of the nervous system

A61K 031/4196 - 1,2,4-Triazoles

A61P 025/16 Drugs for disorders of the nervous system

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/096781 Priority application(s): WO2004/096781

11 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234334-Writing assembly in combination with eraser assembly

2004234311-Container and set and method for forming the same